Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study
- 作者Edward M. Wolin, Ke Hu, Gareth Hughes…
- 卷第72卷
- 期第2期
- 文件大小401.21KB
- 发表时间2013-08
- DOI10.1007/s00280-013-2202-1
- 页码387-395
A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervixR. E. Coleman; J. M. Clarke; M. L. Slevin; J. Sweetenham; C. J. Williams; P. Blake; F. Calman; E. Wiltshaw; P. G. Harper · 1990
Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II studyFrancesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Saggio; Francesca Fabbri; Michele Rosselli; Elisabetta Capomolla; Silvio Rea · 2001
Combination of Ifosfamide, Paclitaxel, and Cisplatin for the Treatment of Metastatic and Recurrent Carcinoma of the Uterine Cervix: A Phase II Study of the Hellenic Cooperative Oncology GroupMeletios A. Dimopoulos; Christos A. Papadimitriou; Kyrillos Sarris; Gerassimos Aravantinos; Charalambos Kalofonos; Dimitra Gika; Georgios M. Gourgoulis; Eleni Efstathiou; Dimosthenis Skarlos; Dimitrios Bafaloukos · 2002
Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix—Final results of a prospective phase II-studyEduard Vrdoljak; Tomislav Omrčen; Žana Saratlija Novaković; Tihana Boraska Jelavić; Tomislav Prskalo; Dario Hrepić; Wolfgang Hamm · 2006
Phase I/II Study of Sequential Dose-Intensified Ifosfamide, Cisplatin, and Etoposide Plus Paclitaxel As Induction Chemotherapy for Poor Prognosis Germ Cell Tumors by the German Testicular Cancer Study GroupHartmann, J. T.; Gauler, T.; Metzner, B.; Gerl, A.; Casper, J.; Rick, O.; Horger, M.; Schleicher, J.; Derigs, G.; Mayer-Steinacker, R.; Beyer, J.; Kuczyk, M. A.; Bokemeyer, C. · Journal of Clinical Oncology · 2007
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)R.E.N. van Rijswijk; J.B. Vermorken; N. Reed; G. Favalli; C. Mendiola; F. Zanaboni; G. Mangili; I. Vergote; J.P. Guastalla; W.W. ten Bokkel Huinink; A.J. Lacave; H. Bonnefoi; S. Tumulo; R. Rietbroek; I. Teodorovic; C. Coens; S. Pecorelli · 2003
Long-Term Results of First-Line Sequential High-Dose Etoposide, Ifosfamide, and Cisplatin Chemotherapy Plus Autologous Stem Cell Support for Patients With Advanced Metastatic Germ Cell Cancer: An Extended Phase I/II Study of the German Testicular Cancer Study GroupSchmoll, H.-J. · Journal of Clinical Oncology · 2003